ModelEdge

Filing Type	20-F
Filing Date	4/2/2026
Updated	4/2/26, 3:40 PM

Filing

Earnings Release

Exhibits

20-FAnnual and Transition Report of Foreign Private Issuers

EX-1.1ARTICLES OF ASSOCIATION OF MDXHEALTH SA (ENGLISH TRANSLATION)

EX-1.2CORPORATE GOVERNANCE CHARTER OF MDXHEALTH SA (ENGLISH TRANSLATION)

EX-2.1DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT

EX-4.33THIRD AMENDMENT TO CREDIT AGREEMENT, DATED AUGUST 5, 2025, BY AND AMONG THE COMPANY, AS GUARANTOR, MDXHEALTH, INC., AS BORROWER, AND ONE OR MORE AFFILIATES OF ORBIMED, AS THE LENDERS AND ADMINISTRATIVE AGENT #

EX-4.35THIRD AMENDMENT TO ASSET PURCHASE AGREEMENT BETWEEN GENOMIC HEALTH, INC. AND MDXHEALTH SA DATED AUGUST 23, 2023

EX-4.36FOURTH AMENDMENT TO ASSET PURCHASE AGREEMENT BETWEEN GENOMIC HEALTH, INC. AND MDXHEALTH SA DATED JANUARY 9, 2026

EX-4.37EQUITY PURCHASE AGREEMENT BY AND AMONG MDXHEALTH SA, EXOSOME DIAGNOSTICS, INC. AND BIO-TECHNE CORPORATION, DATED AUGUST 5, 2025

EX-4.38SUBLEASE AGREEMENT EXOSOME DIAGNOSTICS, INC. AND BIO-TECHNE CORPORATION, DATED SEPTEMBER 15, 2025

EX-12.1CERTIFICATION

EX-12.2CERTIFICATION

EX-13.1CERTIFICATION

EX-13.2CERTIFICATION

EX-15.1CONSENT OF BDO REVISEURS D' ENTREPRISES SRL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM